The speaker develops RADARS, a programmable RNA-guided gene-delivery system that activates only in cells with specific RNA “fingerprints.” Their thesis tackles weak activation when target RNA is rare, creating new mechanisms to bind targets more tightly. These innovations aim to enable safer, cell-specific cancer therapies through precise molecular control.